Pharma Mar (MEX:PHM1N) DeferredTaxAndRevenue: MXN0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:PHM1N Pharma Mar SA MEX:PHM1N
68 GF Score
Price MXN1,608.38
GF Value MXN1,734.34
! 2 Warning Signs
View Full Analysis

What is Pharma Mar DeferredTaxAndRevenue?

Pharma Mar MEX:PHM1N 68 DeferredTaxAndRevenue is MXN0 Mil as of Jun. 2026. GuruFocus rates MEX:PHM1N with a GF Score™ of 68/100 and a GF Value™ of MXN1,734.34. The stock has 2 warning signs investors should review.

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Pharma Mar's current deferred tax and revenue for the quarter that ended in Jun. 2026 was MXN0 Mil.

Pharma Mar DeferredTaxAndRevenue Related Terms

Pharma Mar DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for Pharma Mar's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharma Mar DeferredTaxAndRevenue Chart

Pharma Mar Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
DeferredTaxAndRevenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Pharma Mar Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
MEX:PHM1N
68GF Score
Pharma Mar SA MEX:PHM1N
DeferredTaxAndRevenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about DeferredTaxAndRevenue →
What does a DeferredTaxAndRevenue of MXN0 Mil mean?
Pharma Mar (MEX:PHM1N) has a DeferredTaxAndRevenue of MXN0 Mil as of Jun. 2026. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Pharma Mar.
Is Pharma Mar's DeferredTaxAndRevenue too high?
Pharma Mar's current DeferredTaxAndRevenue is MXN0 Mil. Overall, Pharma Mar has a GF Score™ of 68/100, reflecting its overall financial health beyond just this single metric.
How does Pharma Mar's DeferredTaxAndRevenue compare to VRTX and REGN?
Pharma Mar's DeferredTaxAndRevenue of MXN0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good DeferredTaxAndRevenue for a Biotechnology company?
A good DeferredTaxAndRevenue depends on the Biotechnology industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high DeferredTaxAndRevenue mean?
A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Pharma Mar. Pharma Mar's current DeferredTaxAndRevenue is MXN0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharma Mar stock overvalued right now?
Pharma Mar (MEX:PHM1N) has a current DeferredTaxAndRevenue of MXN0 Mil. The stock's GF Value™ is MXN1,734.34, compared to a current price of MXN1,608.38 — trading 7.3% below its estimated fair value. The current DeferredTaxAndRevenue is MXN0 Mil. Pharma Mar's overall GF Score™ is 68/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is DeferredTaxAndRevenue calculated?
DeferredTaxAndRevenue is calculated from a company's financial statements. For Pharma Mar (MEX:PHM1N), the current DeferredTaxAndRevenue is MXN0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pharma Mar (MEX:PHM1N) Overvalued in 2026?

Based on GuruFocus' analysis, Pharma Mar stock appears to be undervalued. The current stock price of MXN1,608.38 is trading 7.3% below its estimated GF Value™ of MXN1,734.34.

Key valuation signals for MEX:PHM1N:

  • DeferredTaxAndRevenue: MXN0 Mil
  • GF Value™: MXN1,734.34 vs. price of MXN1,608.38 (7.3% below fair value)
  • GF Score™: 68/100 with 2 warning signs

No single metric tells the full story. See the MEX:PHM1N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pharma Mar Business Description

Address Avenida de los Reyes, 1, Poligono Industrial La Mina-norte, Colmenar Viejo, Madrid, ESP, 28770
Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and markets insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.
68GF Score

Get the complete analysis for MEX:PHM1N

DeferredTaxAndRevenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,608.38
Price
MXN1,734.34
GF Value